Overview

Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
0
Participant gender:
All
Summary
We will evaluate the bioavailability of naproxen 375 mg in two formulations
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
POZEN
Treatments:
Naproxen
Criteria
Inclusion Criteria:

- Healthy male or non-pregnant female subjects between 18-55 years as well as other
standard inclusion criteria for a study of this nature

Exclusion Criteria:

- Standard exclusion criteria for a study of this nature